Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tina Marriott Larson Insider Profile
4 Followers
Tina Marriott Larson, President & COO at Recursion Pharmaceuticals, holds 506.85K shares in Recursion Pharmaceuticals (Ticker: RXRX).
Tina Marriott Larson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tina Marriott Larson's holdings
Insider Roles
President & COO
Roles that Tina Marriott Larson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Tina Marriott Larson
Tina Marriott Larson's Trading History
List of latest transactions for each holding click on a transaction to see Tina Marriott Larson's performance on stock
You May Also Like
Tina Marriott Larson insider profile FAQ
What is the percentage of profitable transactions made by Tina Marriott Larson?
The percentage of profitable transactions made by Tina Marriott Larson is ―.
What is the average return per transaction made by Tina Marriott Larson?
The average return per transaction made by Tina Marriott Larson is ―.
What stocks does Tina Marriott Larson hold?
Tina Marriott Larson holds: RXRX stocks.
What was Tina Marriott Larson’s latest transaction?
Tina Marriott Larson latest transaction was an Uninformative Sell of $88.14K.
What was Tina Marriott Larson's most profitable transaction?
Tina Marriott Larson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Tina Marriott Larson's role in Recursion Pharmaceuticals?
Tina Marriott Larson's role in Recursion Pharmaceuticals is President & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.